维普中文期刊产品整合服务
4篇 您的检索式:作者名="Wennan Zhao"
    题名 作者 年代 出处 被引量
1Class I phosphatidylinositol 3-kinase inhibitors for cancer therapy显示文摘The phosphatidylinositol 3-kinase(PI3K) pathway is frequently activated in human cancers.Class I PI3 Ks are lipid kinases that phosphorylate phosphatidylinositol 4,5-bisphosphate(PIP2) at the 3-OH of the inositol ring to generate phosphatidylinositol 3,4,5-trisphosphate(PIP3), which in turn activates Akt and the downstream effectors like mammalian target of rapamycin(m TOR) to play key roles in carcinogenesis. Therefore, PI3 K has become an important anticancer drug target, and currently there is very high interest in the pharmaceutical development of PI3 K inhibitors. Idelalisib has been approved in USA and Europe as the first-in-class PI3 K inhibitor for cancer therapy. Dozens of other PI3 K inhibitors including BKM120 and ZSTK474 are being evaluated in clinical trials. Multifaceted studies on these PI3 K inhibitors are being performed, such as single and combinational efficacy, resistance, biomarkers,etc. This review provides an introduction to PI3 K and summarizes key advances in the development of PI3 K inhibitors.Wennan Zhao Yuling Qiu Dexin Kong 2017Acta Pharmaceutica Sinica B2017,7,1:19
2Automation and optimization of liquid-phase microextraction by gas chromatography显示文摘Gangfeng Ouyang Wennan Zhao Janusz Pawliszyn 2006Journal of Chromatography A2006,,1:1
3Auto-mation and optimization of liquid-phase microextraction by gaschromatography显示文摘Gangfeng Ouyanga Wennan Zhao Janusz Pawliszyn 2007J Chromatography A2007,1138,:1
4Effect of Chemical Cross-linking on Properties of Gelatin/Hyaluronic Acid Composite Hydrogels显示文摘Zhihua Zhou Zhongmin Yang Tianlong Huang Lihua Liu Qingquan Liu Yanmin Zhao Wennan Zeng Qingfeng Yi Dafu Cao 2013Polymer-Plastics Technology and Engineering2013,,1:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费